In 2003, the FIP1L1–PDGFRA fusion was identified in patients with idiopathic hypereosinophilic syndrome and its presence redefined such patients having a neoplasm instead of idiopathic hypereosinophilic syndrome. This evidence concerns the gene PDGFRA and idiopathic hypereosinophilic syndrome.